Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorSingapore National Eye Centre

About this trial

The purpose of this research study is to evaluate a new screening procedure for the early detection and monitoring of Age-related Macular Degeneration (AMD) in community settings and community hospital settings, to identify associated risk factors, and develop personalized monitoring strategies for at-risk individuals throughout the 5 years follow up period, which will allow us to establish prevalence, natural history of progression of early AMD in the community.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 55 years or older

No severe systemic illnesses that prevent study participation

Willing and able to undergo protocol-required procedures for both eyes

Willing and able to provide written informed consent

Disqualifiers

Systemic disorders that preclude reliable clinical examination or multimodal imaging

Poor compliance or severe mental illness that hinders participation

Persons who are unable to give informed consent

Trial population

This study will aim for 1500 participants aged ≥ 55 years from SingHealth Community Outreach Programme, other community-based screening initiatives and Outram Community Hospital (OCH).

Trial design

Design model

Ecologic or community

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

To establish the natural history of AMD in Asian elderly and to identify clinical multimodal imaging, genetic, and metabolomic predictors of progression.

Progression is defined as the change from early signs of AMD to advanced AMD.

Time frame
3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Singapore National Eye Centre

Lead sponsor

Singapore Health Services

Collaborator